Compositions for affecting weight loss

Details for Australian Patent Application No. 2004233846 (hide)

Owner Orexigen Therapeutics, Inc.

Inventors Cowley, Michael Alexander; Weber, Eckard

Agent Cullens

Pub. Number AU-B-2004233846

PCT Pub. Number WO2004/096201

Priority 60/466,838 29.04.03 US

Filing date 21 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 1 July 2010

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096201 Priority application(s): WO2004/096201

1 July 2010 Application Accepted

  Published as AU-B-2004233846

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233848-Artificial valve prosthesis with improved flow dynamics

2004233843-Distal protection device